Orano Med
Romain Marchadier is an experienced engineer currently serving as Ingénieur Méthodes Maintenance at Orano Med since March 2023, focusing on maintenance management systems and project policy development for cancer therapy advancements. Prior to this role, Romain held the position of Ingénieur Projets Pharmaceutique at Catalent Pharma Solutions from September 2016 to March 2023, contributing to various engineering tasks related to pharmaceutical manufacturing, including qualification protocols and HVAC renovations. Romain's early career included positions as a Stagiaire ingénieur and Technicien alternant en métrologie, where responsibilities involved project coordination, 5S implementation, and equipment qualification. Romain holds a Diplôme d'ingénieur from ENSIM Ecole d'ingénieurs Le Mans Université and a DUT in mesures physiques from Université de Limoges.
This person is not in any offices
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.